Hendrik Peter Scholl
Chief Medical Officer
3 filings on record here, covering BLTE. Amounts are the ranges the filer reported, which is how the law requires them to be disclosed.
Filings
CORPORATEFiled 2026-10-05
| Sell | BLTE | BELITE BIO, INC | $32,725 |
| Sell | BLTE | BELITE BIO, INC | $3,951 |
| Sell | BLTE | BELITE BIO, INC | $19,859 |
| Sell | BLTE | BELITE BIO, INC | $8,322 |
| Sell | BLTE | BELITE BIO, INC | $13,072 |
| Sell | BLTE | BELITE BIO, INC | $2,019 |
| Sell | BLTE | BELITE BIO, INC | $2,371 |
| Sell | BLTE | BELITE BIO, INC | $340 |
CORPORATEFiled 2026-06-22
| Sell | BLTE | BELITE BIO, INC | $13,814 |
| Sell | BLTE | BELITE BIO, INC | $542,192 |
| Sell | BLTE | BELITE BIO, INC | $706,959 |
| Sell | BLTE | BELITE BIO, INC | $175,348 |
| Sell | BLTE | BELITE BIO, INC | $14,123 |
CORPORATEFiled 2026-06-17
| Sell | BLTE | BELITE BIO, INC | $282,641 |
| Sell | BLTE | BELITE BIO, INC | $108,331 |
| Sell | BLTE | BELITE BIO, INC | $438,260 |
| Sell | BLTE | BELITE BIO, INC | $75,915 |
| Sell | BLTE | BELITE BIO, INC | $14,183 |
| Sell | BLTE | BELITE BIO, INC | $63,988 |
| Sell | BLTE | BELITE BIO, INC | $272,314 |
| Sell | BLTE | BELITE BIO, INC | $150,097 |
Source records are public filings: House and Senate periodic
transaction reports, Office of Government Ethics filings, and SEC Form 4 filings. Amounts
are reported as ranges by law, not exact figures, and filings arrive on a legal delay.
Eltrove reports what was filed. Nothing here is investment advice or a recommendation.